Baird analyst Michael Ha lowered the firm’s price target on Molina Healthcare (MOH) to $331 from $405 and keeps an Outperform rating on the shares. The firm lowered its estimates to account fortheir base case expectation of incremental MLR pressure in 3Q/4Q.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Medicare paid insurers approx $4.2B for home diagnoses, WSJ reports
- Closing Bell Movers: Tesla gains 12% as Q3 earnings beat estimates
- Molina Healthcare reports Q3 adjusted EPS $6.01, consensus $5.94
- Molina Healthcare sees FY24 adjusted EPS at least $23.50, consensus $23.51
- Notable companies reporting after market close